Florence J. Hardy

Florence J. Hardy

Auto-generated profile, based on publicly available information

Florence J. Hardy

Department of Chemistry & Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Nature
Verified
Journal Article
Closed access
PDF file
JTJonathan S. Trimble
Jonathan S. Trimble
RCRebecca Crawshaw
Rebecca Crawshaw
FHFlorence J. Hardy
Florence J. Hardy
CLColin W. Levy
Colin W. Levy
MBMurray J. B. Brown
Murray J. B. Brown
AGAnthony P. Green
Anthony P. Green

3 July 2024 in Chemical Reviews
Verified
Journal Article
Open access
ZBZachary Birch-Price
Zachary Birch-Price
FHFlorence J. Hardy
Florence J. Hardy
TLThomas M. Lister
Thomas M. Lister
AKAnna R. Kohn
Anna R. Kohn
AGAnthony P. Green
Anthony P. Green
In recent years, powerful genetic code reprogramming methods have emerged that allow new functional components to be embedded into proteins as noncanonical amino acid (ncAA) side chains. In this review, we will illustrate how the availability of an expanded set of amino acid building blocks has opened a wealth of new opportunities in enzymology and biocatalysis research. Genetic code reprogramming has provided new insights into enzyme mechanisms by allowing introduction of new spectroscopic probes and the targeted replacement of individual atoms or functional groups. NcAAs have also been used to develop engineered biocatalysts with improved activity, selectivity, and stability, as well as enzymes with artificial regulatory elements that are responsive to external stimuli. Perhaps most ambitiously, the combination of genetic code reprogramming and laboratory evolution has given rise to new classes of enzymes that use ncAAs as key catalytic elements. With the framework for developing ncAA-containing biocatalysts now firmly established, we are optimistic that genetic code reprogramming will become a progressively more powerful tool in the armory of enzyme designers and engineers in the coming years.

7 September 2023 in ACS Catalysis
Verified
Journal Article
Open access
EHEuan J. Hossack
Euan J. Hossack
FHFlorence J. Hardy
Florence J. Hardy
AGAnthony P. Green
Anthony P. Green

6 May 2025 in Nature Chemistry
Verified
Journal Article
Open access
PDF file
RCRebecca Crawshaw
Rebecca Crawshaw
RSRoss Smithson
Ross Smithson
JHJohannes Hofer
Johannes Hofer
FHFlorence J. Hardy
Florence J. Hardy
GRGeorge W. Roberts
George W. Roberts
AGAnthony P. Green
Anthony P. Green
The development of [2 + 2] cyclases containing benzophenone triplet sensitizers highlights the potential of engineered enzymes as a platform for stereocontrolled energy transfer photocatalysis. However, the suboptimal photophysical features of benzophenone necessitates the use of ultraviolet light, limits photochemical efficiency and restricts the range of chemistries accessible. Here we engineer an orthogonal Methanococcus jannaschii tyrosyl-tRNA synthetase/tRNA pair for encoding thioxanthone triplet sensitizers into proteins, which can efficiently harness visible light to drive photochemical conversions. Initially, we developed an enantioselective [2 + 2] cyclase that is orders of magnitude more efficient than our previously developed photoenzymes (k cat = 13 s−1, >1,300 turnovers). To demonstrate that thioxanthone-containing enzymes can enable more challenging photochemical conversions, we developed a second oxygen-tolerant enzyme that can steer selective C–H insertions of excited quinolone substrates to afford spirocyclic β-lactams with high selectivity (99% e.e., 22:1 d.r.). This photoenzyme also suppresses a competing substrate decomposition pathway observed with small-molecule sensitizers, underscoring the ability of engineered enzymes to control the fate of excited-state intermediates.

4 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
AHAmy E. Hutton
Amy E. Hutton
JFJake Foster
Jake Foster
RCRebecca Crawshaw
Rebecca Crawshaw
FHFlorence J. Hardy
Florence J. Hardy
LJLinus O. Johannissen
Linus O. Johannissen
AGAnthony P. Green
Anthony P. Green
Directed evolution of computationally designed enzymes has provided new insights into the emergence of sophisticated catalytic sites in proteins. In this regard, we have recently shown that a histidine nucleophile and a flexible arginine can work in synergy to accelerate the Morita-Baylis-Hillman (MBH) reaction with unrivalled efficiency. Here, we show that replacing the catalytic histidine with a non-canonical Nδ-methylhistidine (MeHis23) nucleophile leads to a substantially altered evolutionary outcome in which the catalytic Arg124 has been abandoned. Instead, Glu26 has emerged, which mediates a rate-limiting proton transfer step to deliver an enzyme (BHMeHis1.8) that is more than an order of magnitude more active than our earlier MBHase. Interestingly, although MeHis23 to His substitution in BHMeHis1.8 reduces activity by 4-fold, the resulting His containing variant is still a potent MBH biocatalyst. However, analysis of the BHMeHis1.8 evolutionary trajectory reveals that the MeHis nucleophile was crucial in the early stages of engineering to unlock the new mechanistic pathway. This study demonstrates how even subtle perturbations to key catalytic elements of designed enzymes can lead to vastly different evolutionary outcomes, resulting in new mechanistic solutions to complex chemical transformations.

9 September 2023 in Journal of the American Chemical Society
Verified
Journal Article
Open access
Jingming ZhaoJingming Zhao
Jingming Zhao
YZYing Zhuo
Ying Zhuo
DDDaniel E. Diaz
Daniel E. Diaz
MSMuralidharan Shanmugam
Muralidharan Shanmugam
ATAbbey J. Telfer
Abbey J. Telfer
AGAnthony P. Green
Anthony P. Green
Oxygenase and peroxygenase enzymes generate intermediates at their active sites which bring about the controlled functionalization of inert C-H bonds in substrates, such as in the enzymatic conversion of methane to methanol. To be viable catalysts, however, these enzymes must also prevent oxidative damage to essential active site residues, which can occur during both coupled and uncoupled turnover. Herein, we use a combination of stopped-flow spectroscopy, targeted mutagenesis, TD-DFT calculations, high-energy resolution fluorescence detection X-ray absorption spectroscopy, and electron paramagnetic resonance spectroscopy to study two transient intermediates that together form a protective pathway built into the active sites of copper-dependent lytic polysaccharide monooxygenases (LPMOs). First, a transient high-valent species is generated at the copper histidine brace active site following treatment of the LPMO with either hydrogen peroxide or peroxyacids in the absence of substrate. This intermediate, which we propose to be a CuII-(histidyl radical), then reacts with a nearby tyrosine residue in an intersystem-crossing reaction to give a ferromagnetically coupled (S = 1) CuII-tyrosyl radical pair, thereby restoring the histidine brace active site to its resting state and allowing it to re-enter the catalytic cycle through reduction. This process gives the enzyme the capacity to minimize damage to the active site histidine residues "on the fly" to increase the total turnover number prior to enzyme deactivation, highlighting how oxidative enzymes are evolved to protect themselves from deleterious side reactions during uncoupled turnover.